SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Onishi J, Umegaki H, Suzuki Y, Nakamura A, Endo H, Iguchi A. Impact of behavioral and psychological symptoms of dementia (BPSD) and cared environment on caregiver burden. Jpn J Geriatr Psychiatry 2003; 14: 465473 (in Japanese with an English abstract).
  • 2
    Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 2001; 28 (Suppl. 1): S96S107.
  • 3
    Zaudig M. A risk–benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Saf 2000; 23: 183195.
  • 4
    Gareri P, Cotroneo A, Lacava R et al. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Arch Gerontol Geriatr Suppl 2004; 9: 207215.
  • 5
    Tanaka T, Takeda M. Senile dementia Alzheimer's type. Jpn J Geriatr Psychiatry 2003; 14: 783794 (in Japanese).
  • 6
    Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: A randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999; 60: 107115.
  • 7
    Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 205209.
  • 8
    Angelini A, Bendini C, Neviani F, Neri M. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: Is the long lasting use of atypical antipsychotic drugs useful and safe? Arch Gerontol Geriatr 2007; 44: 3543.
  • 9
    Maruoka N. Clinical data about fall. Nursing Today 2007; 22: 3439 (in Japanese).
  • 10
    Brodaty H, Ames D, Snowdon J et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003; 64: 134143.
  • 11
    Van Iersel MB, Zuidema SU, Koopmans RT, Verhey FR, Olde Rikkert MG. Antipsychotics for behavioural and psychological problems in elderly people with dementia: A systematic review of adverse events. Drugs Aging 2005; 22: 845858.
  • 12
    Suh GH, Shah A. Effect of antipsychotics on mortality in elderly patients with dementia: A 1-year prospective study in a nursing home. Int Psychogeriatr 2005; 17: 429441.
  • 13
    Haupt M, Cruz-Jentoft A, Jeste D. Mortality in elderly dementia patients treated with risperidone. J Clin Psychopharmacol 2006; 26: 566570.
  • 14
    Katz I, De Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: A meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry 2007; 22: 475484.
  • 15
    Omelan C. Approach to managing behavioural disturbances in dementia. Can Fam Physician 2006; 52: 191199.
  • 16
    Herrmann N, Lanctôt KL. Atypical antipsychotics for neuropsychiatric symptoms of dementia: Malignant or maligned? Drug Saf 2006; 29: 833843.